Metabolomics Market Overview:
Global Metabolomics Market was valued at $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. Metabolomics is the study and analysis of the biochemical processes involving intermediates and byproducts of metabolic activities. These products are known as metabolomes, which reflect the cluster of all metabolites involved in various reactions in an organism, which include metabolic intermediates, signaling molecules, secondary metabolites, and hormones.
Metabolomics includes the utilization of various analytical techniques for the determination of metabolites such as, spectroscopy, chromatography, and multivariate analysis. Metabolites are closely related to the phenotype of an organism, and can be used for a wide range of applications such as, substantial equivalence testing, phenotyping of genetically modified plants, identification of gene function, and biotic-abiotic stress reaction analysis. Furthermore, it facilitates researchers and scientists to calculate physiological effects and observe adverse reaction of drugs on an organism.
Global Metabolomics Market Segmentation
The global metabolomics market is segmented based on product & service, application, indication, and geography. Based on product & service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further divided into separation techniques and detection techniques. The separation techniques segment is further classified into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further categorized into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. The metabolomics bioinformatics tools & services segment is further bifurcated into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Based on indication, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Metabolomics Market, by Region
The global metabolomics market is driven by increase in adoption of metabolomics in precision medicine and advent of diagnostics tests for diagnosis of chronic diseases. Moreover, technological advancements in analytical techniques and upsurge in R&D expenditure are expected to boost the market growth.
The report provides extensive competitive analysis and profiles of key market players, such as Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, LECO Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc. The other players in the market include Kore Technologies, Ltd., Dani Instruments S.P.A., Perkinelmer, Inc., and Evans Analytical Group LLC.
Key Benefits :
- The report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
- Market estimations of the industry are provided based on the comprehensive analysis of the key developments in the industry.
- In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
- The developmental strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the global market.
Metabolomics Market Key Segments:
By Product & Service
- Metabolomics Instruments
- Separation Techniques
- High-performance Liquid Chromatography
- Gas Chromatography
- Ultra-performance Liquid Chromatography
- Capillary Electrophoresis.
- Detection Techniques
- Mass Spectrometry
- Nuclear Magnetic Resonance Spectroscopy
- Surface-based Mass Analysis
- Separation Techniques
- Metabolomics Bioinformatics Tools & Services
- Bioinformatics Tools and Database
- Bioinformatics Services
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Functional Genomics
- Personalized Medicine
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- North America
- The Netherlands
- Rest of Europe
- South Korea
- New Zealand
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA